The overall objective of this continuing medical education program is to improve the ophthalmic health of
Friday, May 2, 2014
Fort Worth Convention Center, Room 100
6 AMA PRA Category 1 Credits™
1 Hour Medical Ethics and/or Professional Responsibility
Friday Objectives
• Evaluate the risk, surgical time, expense and efficacy of 2 new technologies in cataract surgery.
• Evaluate the role of inflammation in diagnosis and treatment of Dry Eye Syndrome.
• Evaluate the role of genotyping of retinal diseases.
• Contrast novel techniques for management of the malpositioned intraocular lens implant.
• Discuss the integration of health information technology into the ophthalmology practice for quality of care enhancement;
Summarize meaningful use stage two and eligibility for federal EHR incentives through the Medicare and Medicaid
programs; and explain potential for quality improvement through meaningful use stage two EHR quality reports, patient
engagement, and care coordination.
• Determine points in the care process where a surgical checklist is needed; Examine the ophthalmic-specific protocol
developed by eye organizations; Develop a plan to implement the protocol in all care settings.
• Summarize the need for ophthalmologists to get involved with advocacy as another means of protecting patients from harm.
7:15 – 8 am
8 – 8:05 am
Breakfast in the Ophthalmology Pavilion
Welcome & Instructions
Session 1: Innovations in Cataract Surgery
8:05 – 8:10 am
Overview of Session 1
James P. McCulley, MD, FRCOphth(UK), FACS, moderator
8:10 – 8:30 am
Inter-operative Aberrometry
Stephen Slade, MD
John H. and Anna Marie Fish Memorial Speaker
8:30 – 8:55 am
Point: Innovations in Cataract Surgery: Femtosecond Cataract Surgery
Stephen Slade, MD
8:55 – 9 am
Counterpoint: Femtosecond Cataract Surgery is not ready for Prime Time
Tyrone McCall, MD
9 – 9:10 am
Point-Counterpoint by Presenters
9:10 – 9:30 am
Refreshment Break in the Ophthalmology Pavilion
Session 2: Subspecialty Review for the Comprehensive Ophthalmologist
9:30 – 9:35 am
Overview of Session 2
Moderator: Sidney K. Gicheru, MD
9:35 – 10 am
Integrated Metrology for Ocular Surface Evaluation
James V. Aquavella, MD
10 – 10:25 am
Genetic Eye Diseases: An Approach for the Comprehensive Ophthalmologist
Alan E. Kimura, MD, MPH
10:25 – 10:50 am
Advanced IOL Power Calculations for the Cataract and Refractive Surgeon
Jack T. Holladay, MD, MSEE, FACS
10:50 – 11 am
Panel Discussion by Presenters
Session 3: Ethics & Insurance Presentations
11 am – Noon
Ethics Hour: Meaningful Use - Stage 2 for the Ophthalmologist
Shannon Vogel
Noon – 12:45 pm
Box Lunch in the Ophthalmology Pavilion
12:45 – 2:15 pm
OMIC: Using Checklists to Prevent Patient Harm
Hans K. Bruhn, MHS
Session 4: Advocacy
2:15 – 2:20 pm
Overview of Session 4
David G. Shulman, MD, moderator
2:20 – 2:40 pm
Why Should Texas Ophthalmologists be Very Afraid?
Jay Propes
2:40 – 3:05 pm
Legislative Update: Where is Medicine Headed and How can MDs get Involved?
Representative Bennett Ratliff
3:05 – 3:15 pm
3:15 pm
3:15 - 3:30 pm
3:30 - 4:30 pm
TMA General Session
5 – 7:00 pm
TOA President’s Reception – Omni Hotel, Poolside Deck, 3rd floor
Saturday, May 3, 2014
Fort Worth Convention Center, Room 100
4.5 AMA PRA Category 1 Credits™
Saturday Objectives:
• Summarize research projects of regional ophthalmology residents, including new techniques and information in bare sclera
excision, electronic medical records, ocular trauma, diabetic retinopathy, anterior polar cataracts in children, and
hydroxychloroquine use.
• Debate the role of the comprehensive ophthalmologist in intravitreal injections.
• Outline new techniques to treat duct obstruction in a pediatric population.
• Summarize the latest information regarding the diagnosis, treatment and management of Multiple Sclerosis from an
ophthalmic perspective.
• Evaluate the role of Micro-invasive Glaucoma surgery in the treatment of Glaucoma.
• Recognize that the eyelid region is susceptible to skin cancer, and employ new management techniques.
• Weigh the benefits of various treatment options for patients with small to medium uveal melanomas.
• Explain the threats to patient safety in Texas’ regulatory and legislative arenas.
• Explain how the ACA and its insurance exchanges will impact the ophthalmologist.
• Summarize the details of running for public office, or helping another run for public office.
8:30 – 9 am
Breakfast in the Ophthalmology Pavilion
9 – 9:05 am
Welcome & Instructions
Session 1: Resident Competition: The Barry Uhr, MD, Memorial Prize in Comprehensive
Moderator: Sidney K. Gicheru, MD
9:05 – 9:15 am
Electronic Medical Records in Ophthalmology: Patient and Physician Perspectives
Claudia Hooten, MD (UT Houston)
9:15 – 9:25 am
0.01 mg Mitomycin C Subconjunctival Injection One Month prior to Bare Sclera
Excision is an Effective and Safe Technique for Pterygium Treatment
Mircea Coca, MD, PhD (UT Medical Branch)
9:25 – 9:35 am
Inflammation after Ocular Trauma
Philip Lieu, MD (Texas Tech University HSC)
9:35 – 9:45 am
Effect of Panretinal Photocoagulation for Diabetic Retinopathy on Retinal Nerve
Fiber Layer and Visual Field
Peng Lei, MD (UT Southwestern Medical Center)
9:45 – 9:55 am
Characteristics of Anterior Polar Cataracts in Children
Lena Dixit, MD (Baylor College of Medicine)
9:55 – 10:05 am
Multifocal Electroretinography Findings in Patients with long-term
Hydroxychloroquine Use and Suspected Toxicity
Negin Agange, MD, MBA (UTHSC San Antonio)
Session 2: Subspecialty Review for the General Ophthalmologist
10:05 – 10:10 am
Overview of Session 2
Barbara A. Smythe, MD, moderator
10:10 – 10:20 am
Point: Intravitreal Injections by Retina Specialists Only
Gregory Kozielec, MD
10:20 – 10:25 am
Counterpoint: Intravitreal Injections should be done by Comprehensive
John M. Haley, MD
10:25 – 10:30 am
10:30 – 10:55 am
Refreshment Break in the Ophthalmology Pavilion
10:55 – 11:15 am
The Insider’s Guide to Modern Surgical Treatment of Neonatal Nasolacrimal Duct
David K. Coats, MD
11:15 – 11:35 am
Neuro-ophthalmic Manifestations of Multiple Sclerosis
Ray Jones, MD
11:35 – 11:55 am
Minimally Invasive Glaucoma Surgery (MIGS): Current Concepts and Techniques
Arvind Neelakantan MD, FRCOphth
11:55 am – 12:15 pm Management of Eyelid Neoplasms for the Comprehensive Ophthalmologist
Vikram D. Durairaj, MD, FACS
12:15 – 12:35 pm:
Update on the Management of Uveal Tumors
Dan S. Gombos, MD
12:35 – 1:40 pm
Boxed Lunch and TOA Annual Member Business Meeting
Session 3: Advocacy & Insurance Update
1:40 – 1:45 pm
Overview of Session 3
Aaron M. Miller, MD, moderator
1:45 – 2:10 pm
Firsthand AAO Experience in Louisiana, Oklahoma and Kentucky
Cynthia Bradford, MD
2:10 – 2:35 pm
The Affordable Care Act: Understanding its Impact on Health Care Providers
Paul Hain, MD
2:35 – 3 pm
Running a Political Campaign: Personally or Helping your Congressperson
Lyle Thorstenson, MD
3 – 3:10 pm
3:10 pm
James V. Aquavella, MD
Catherine E. Aquavella Distinguished Professor of Ophthalmology
Director, Ocular Surface Laboratory
University of Rochester Flaum Eye Institute
Rochester, NY
Cynthia Bradford, MD
Department of Ophthalmology
University of Oklahoma
Dean A. McGee Eye Institute
AAO Senior Secretary for Advocacy
Oklahoma City, OK
Hans K. Bruhn, MHS
Risk Management Department
Ophthalmic Mutual Insurance Company- OMIC
San Francisco, CA
David K. Coats, MD
Professor of Ophthalmology
Baylor College of Medicine, Texas Children's Hospital
President, Texas Ophthalmological Association
Houston, TX
Vikram D. Durairaj, MD, FACS
Texas Oculoplastic Consultants
Oculoplastic and Orbital Surgery, Co-Fellowship Director
Austin, TX
Clinical Professor of Ophthalmology and Ototlaryngology – Head and Neck Surgery
University of Colorado
Denver, CO
Sidney K. Gicheru, MD
LaserCare Eye Center, PA
TOA Program Director and President-Elect
Irving, TX
Dan S. Gombos, MD
Professor & Chief, Section of Ophthalmology
MD Anderson Cancer Center
Clinical Co-Director
The Retinoblastoma Center of Houston
Houston, TX
Paul Hain, MD
Medical Director
Blue Cross & Blue Shield of Texas
Richardson, TX
John M. Haley, MD
Garland Eye Associates
Chair, TOA Liaison Committee to Third Party Payors
Garland, TX
Jack T. Holladay, MD, MSEE, FACS
Clinical Professor
Baylor College of Medicine
Houston, TX
Ray Jones, MD
Associate Professor
Department of Ophthalmology
UT Southwestern Medical Center
Dallas, TX
Alan E. Kimura, MD, MPH
Colorado Retina Associates
Denver, CO
Gregory Kozielec, MD
Retina Institute of Texas, PA
Dallas, TX
Aaron M. Miller, MD
Houston Eye Associates
The Woodlands, TX
Tyrone McCall, MD
Cornea Associates of Texas
Dallas, TX
James P. McCulley, MD, FRCOphth(UK), FACS
The David Bruton, Jr. Chair in Ophthalmology
Professor and Chairman
Department of Ophthalmology
UT Southwestern Medical Center
Dallas, TX
Arvind Neelakantan MD, FRCOphth
Glaucoma Center of Texas
Dallas, TX
Jay Propes
TOA Legislative Consultant
The Graydon Group
Austin, TX
Representative Bennett Ratliff
Texas District 115
Carrollton, TX
David G. Shulman, MD
Clinical Professor of Ophthalmology
UTHSC San Antonio
Chair, TOA Committee on Legislative Activities
San Antonio, TX
Stephen Slade, MD
Slade & Baker Vision Center
Houston, TX
Barbara A. Smythe, MD
Glaucoma Consultants of Texas
Grapevine, TX
Lyle Thorstenson, MD
Associate Professor of Ophthalmology
UT Southwestern Medical Center
Nacogdoches, TX
Shannon Vogel
Health Information Technology
Texas Medical Association
Austin, TX